started · updated
BioNTech to close three German production sites after failed sale attempts
BioNTech has announced the phased closure of three major production facilities in Germany—Tübingen, Marburg, and Idar-Oberstein—after failing to find suitable buyers or investors. The decision follows a significant decline in global demand for COVID-19 vaccines, which had previously driven massive capacity expansions. The closures are expected to affect approximately 1,800 employees across these sites and a facility in Singapore.
The shutdown schedule is staggered: the Tübingen site is slated to close by the end of 2027, Marburg in early 2028, and Idar-Oberstein by the end of 2028. BioNTech has reached agreements with works councils to implement socially responsible measures, including additional severance packages for affected staff.
This restructuring is part of a broader strategic shift. The company aims to reduce its cost structure—projecting annual savings of approximately 500 million euros by 2029—to redirect resources toward its oncology pipeline. BioNTech is increasingly focusing its research and development on cancer treatments, specifically utilizing mRNA-based immunotherapies and antibody-drug conjugates.
Entities
Berenberg · BioNTech · Bosch · CureVac · Germany · Idar-Oberstein · Marburg · Nuremberg · Nürnberg · OncoC4 · Pfizer · Tübingen
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 15 SOURCES] BioNTech is shifting its strategic focus toward oncology and cancer medicine. www.sozcu.com.tr · www.leinetal24.de · athina984.gr · www.capital.gr · www.drweb.de · +6 more
- [DISPUTED] Bosch plans to cut approximately 900 jobs at its Nuremberg plant by 2029. nius.de · www.finanzen.at · www.nordbayern.de
- [● 25 SOURCES] Approximately 1,800 employees are affected by the BioNTech site closures in Germany. www.sozcu.com.tr · www.leinetal24.de · athina984.gr · www.capital.gr · www.drweb.de · +15 more
- [● 28 SOURCES] The Idar-Oberstein facility is scheduled to close by the end of 2028. www.sozcu.com.tr · www.leinetal24.de · athina984.gr · www.capital.gr · www.drweb.de · +18 more
- [● 28 SOURCES] The Marburg facility is scheduled to close in early 2028. www.sozcu.com.tr · www.leinetal24.de · athina984.gr · www.capital.gr · www.drweb.de · +18 more
- [DISPUTED] Bosch is reducing its workforce in Nuremberg by about half of its 1,800 employees. nius.de · www.finanzen.at · www.nordbayern.de
- [● 28 SOURCES] The Tübingen facility is scheduled to close by the end of 2027. www.sozcu.com.tr · www.leinetal24.de · athina984.gr · www.capital.gr · www.drweb.de · +18 more
- [● 28 SOURCES] BioNTech is closing three production sites in Germany because no buyers were found. www.sozcu.com.tr · www.leinetal24.de · athina984.gr · www.capital.gr · www.drweb.de · +18 more
- [● 21 SOURCES] Approximately 1,800 employees are affected by the BioNTech site closures. www.sozcu.com.tr · www.leinetal24.de · athina984.gr · www.capital.gr · www.drweb.de · +11 more
- [● 27 SOURCES] BioNTech will close three production sites in Germany: Tübingen, Marburg, and Idar-Oberstein. www.sozcu.com.tr · www.leinetal24.de · athina984.gr · www.capital.gr · www.drweb.de · +17 more
- [● 27 SOURCES] The company is shifting its focus toward oncology and mRNA-based immunotherapies. www.sozcu.com.tr · www.leinetal24.de · athina984.gr · www.capital.gr · www.drweb.de · +17 more
- [● 27 SOURCES] BioNTech failed to find buyers for the three German production sites. www.sozcu.com.tr · www.leinetal24.de · athina984.gr · www.capital.gr · www.drweb.de · +17 more